SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Charts for Quick CASH $$$

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Galirayo who wrote (7998)6/7/1998 12:07:00 AM
From: scaram(o)uche  Read Replies (1) of 9262
 
[ chat, Ray ]

>> Hey!! Rick! You around? <<

Yup, even caught you talking about stuff like phase III trials. Just a tad fundamental?

:-)

I see we've reeled MZ into the thread.

TTNP and REGN.... I'll defer to Miljenko for opinions about both. For REGN, you buy a lot of science and good cash flow through labs. For TTNP, you get iloperidone. I agree, good news will really cause either one to get up and move. The negatives?...... with REGN, you get early-stage projects and later-stage stuff that looks lifeless. With TTNP, you get some major investors that have a track record of making money, regardless of whether or not a company is successful. Not necessarily bad given the perspective of this thread, the issue may tend to be more volatile than the underlying science should dictate.

Cheers! Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext